Neuropsychiatric aspects of progressive supranuclear palsy

Neurology

Volumn 47, Issue 5, 1996, Pages 1184-1189

  Litvan, Irene ^a,d   Mega, Michael S ^b,c   Cummings, Jeffrey L ^b,c   Fairbanks, Lynn ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGITATION; ALZHEIMER DISEASE; ANXIETY; APATHY; ARTICLE; DISEASE ASSOCIATION; DYSPHORIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SCORING SYSTEM;

EID: 0029854681     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.5.1184     Document Type: Article

References (60)

1. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974;37:121-130.
2. Gambier J, Masson M, Viader F, Limodin J, Strube A. Frontal syndrome of progressive supranuclear palsy. Rev Neurol (Paris) 1985;141:528-536.
3. Pillon B, Dubois B, Lhermitte F, Agid Y. Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease. Neurology 1986;36: 1179-1185.
4. Dubois B, Pillon B, Legault F, Agid Y, Lhermitte F. Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson's disease. Arch Neurol 1988;45:1194-1199.
5. Cummings JL, Benson DF. Psychological dysfunction accompanying subcortical dementias. Annu Rev Med 1988;39:53-61.
6. Litvan I, Grafman J, Gomez C, Chase T. Memory impairment in patients with progressive supranuclear palsy. Arch Neurol 1989;46:765-767.
7. Grafman J, Litvan I, Gomez C, Chase TN. Frontal lobe function in progressive supranuclear palsy. Arch Neurol 1990;47: 553-558.
8. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991;41:634-643.
9. Johnson R Jr, Litvan I, Grafman J. Progressive supranuclear palsy: altered sensory processing leads to degraded cognition. Neurology 1991;41:1257-1262.
10. Johnson RJ. Event-related brain potentials. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992;122-154.
11. Litvan I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl 1994;42:69-78.
12. Blin J, Baron JC, Dubois B, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990;47:747-752.
13. Grafman J, Litvan I, Stark M. Neuropsychological features of progressive supranuclear palsy. Brain Cogn 1995;28:311-320.
14. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival. J Neurol Neurosurg Psychiatry 1996;60:615-620.
15. Deutsch LH, Bylsma FW, Rovner BW, Steele C, Folstein MF. Psychosis and physical aggression in probable Alzheimer's disease. Am J Psychiatry 1991;148:1159-1163.
16. Cummings JL, Diaz C, Levy M, Binetti G, Litvan I. Behavioral syndromes in neurodegenerative diseases: frequency and significance. Sem Neuropsychiatry; in press.
17. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990;147:1049-1051.
18. Morriss RK, Rovner BW, Folstein MF, German PS. Delusions in newly admitted residents of nursing homes. Am J Psychiatry 1990;147:299-302.
19. O'Donnell BF, Drachman DA, Barnes HJ, Peterson KE, Swearer JM, Lew RA. Incontinence and troublesome behaviors predict institutionalization in dementia. J Geriatr Psychiatry Neurol 1992;5:45-52.
20. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43: 2227-2229.
21. Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-671.
22. Rabins PV, Mace NL, Lucas MJ. The impact of dementia on the family. JAMA 1982;248:333-345.
23. Sadler JZ, Kurtz NM, Rush AJ. Progressive supranuclear palsy presenting as pseudodementia. Psychosomatics 1984;25: 713-714.
24. Schneider LS, Chui HC. Progressive supranuclear palsy manifesting with depressive features. J Am Geriatr Soc 1986;34: 663-665.
25. Schneider LS, Gleason RP, Chui HC. Progressive supranuclear palsy with agitation: response to trazodone but not to thiothixine or carbamazepine. J Geriatr Psychiatry Neurol 1989;2:109-112.
26. Trzepacz P, Murcko A, Gillespie M. Progressive supranuclear palsy misdiagnosed as schizophrenia. J Nerv Ment Dis 1985; 173:377-378.
27. Destee A, Gray F, Parent M, et al. Obsessive-compulsive behavior and progressive supranuclear palsy. Rev Neurol (Paris) 1990;146:12-18.
28. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996;46:131-135.
29. Cooper JK, Mungas D, Weiler PG. Relation of cognitive status and abnormal behaviors in Alzheimer's disease. J Am Geriatr Soc 1990;38:867-870.
30. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992;4:134-139.
31. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein PH. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
32. Rubin EH, Morris JC, Storandt M, Berg L. Behavioral changes in patients with mild senile dementia of the Alzheimer's type. Psychiatry Res 1987;21:55-62.
33. Petry S, Cummings JL, Hill MA, Shapira J. Personality alterations in dementia of the Alzheimer type. Arch Neurol 1988; 45:1187-1190.
34. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996;46:922-930.
35. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44: 2015-2019.
36. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathological criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Press, 1994.
38. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group, Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
39. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state:" a practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
40. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, eds. Geriatric psychiatry. New York, NY: Grune & Stratton, 1976.
41. Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology 1981; 31:645-650.
42. Taylor AE, Saint-Cyr JA, Lang AE. Parkinson's disease and depression: a critical reevaluation. Brain 1986;109:279-292.
43. Sano M, Stern Y, Williams J, Cote L, Rostenstein R, Mayeux R. Coexisting dementia and depression in Parkinson's disease. Arch Neurol 1989;46:1284-1286.
44. Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG. Depression in Parkinson's disease. J Nerv Ment Dis 1990;178:27-31.
45. Mayeux R. Parkinson's disease: a review of cognitive and psychiatric disorders. Neuropsychiatry Neuropsychol Behav Neurol 1990;3:3-14.
46. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992;149:443-454.
47. Troster AI, Paolo AM, Lyons KE, Glatt SL, Hubble JP, Koller WC. The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer disease. Neurology 1995;45:672-676.
48. Tison F, Dartigues JF, Auriacombe S, Letenneur L, Boller F, Alperovitch A. Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals. Neurology 1995;45:705-708.
49. Burn DJ, Sawle GV, Brooks DJ. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J Neurol Neurosurg Psychiatry 1994;57:278-84.
50. Blin J, Horwitz B, Baron J, Agid Y. Does frontal cortex hypometabolism in progressive supranuclear palsy result from subcortical dysfunction? Eur J Neurol 1995;1:221-228.
51. Agid Y, Javoy-Agid F, Ruberg M, et al. Progressive supranuclear palsy: anatomoclinical and biochemical considerations. Adv Neurol 1987;45:191-206.
52. Takahashi H, Oyanagi K, Takedo S, et al. Occurrence of 15-nm-wide straight tubules in neocortical neurons in progressive supranuclear palsy. Acta Neuropathol (Berl) 1989;79: 233-239.
53. Hauw J-J, Venry M, Delaere P, et al. Constant neurofibrillary changes in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Neurosci Lett 1990;119: 182-186.
54. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
55. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol 1993;50:873-880.
56. Jellinger KA, Bancher C. Neuropathology. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992;44-88.
57. Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 1987;84:5976-5980.
58. Javoy-Agid F. Cholinergic and peptidergic systems in PSP. J Neural Transm Suppl 1994;42:205-218.
59. Levy R, Ruberg M, Herrero MT, et al. Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA. Neurology 1995;45:127-134.
60. Menza MA, Cocchiola J, Golbe LI. Psychiatric symptoms in progressive supranuclear palsy. Psychosomatics 1995;36:550-554.